logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jonathan W. Goldman

David Geffen School of Medicine at UCLA
H指数:67
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A CCL21 gene-modified dendritic cell vaccine combined with pembrolizumab in advanced non-small cell lung cancer: a phase I trial

CCL21基因修饰的树突状细胞疫苗联合帕博利珠单抗治疗晚期非小细胞肺癌：一项I期临床试验

Nature Communications
IF15.7
2026-10-040
OA
Michael S. Oh; Aaron E. Lisberg; Camelia Dumitras; Linh M. Tran; Ramin Salehi-Rad; Kostyantyn Krysan; Raymond J. Lim; Maryam Shabihkhani; Tahmineh Romero; Shuo Li; Weihua Zeng; Zhe Jing; Rui Li; Bitta P. Kahangi; Olga Tsvetkova; Robert D. Suh; Fereidoun Abtin; Scott J. Genshaft; Scott S. Oh; Gregory A. Fishbein; Daniel R. Greenwald; Kanwarpal S. Kahlon; Sidharth R. Anand; Shahryar Ashouri; Jonathan W. Goldman; Jay M. Lee; Xianghong J. Zhou; David A. Elashoff; Edward B. Garon; Bin Liu; Steven M. Dubinett
Small Cell Lung Cancer, Version 2.2026 Featured Updates to the NCCN Guidelines

小细胞肺癌，2026年第2版NCCN指南特色更新

Journal of the National Comprehensive Cancer Network
IF16.4
2026-01-010
PRE
Ganti, Apar Kishor P.; Loo, Billy W.; Badiyan, Shahed; Bassetti, Michael; Bestvina, Christine; Chiang, Anne; Choudhury, Noura; D'Avella, Christopher A.; Daly, Megan; Dowlati, Afshin; Edelman, Martin; Florsheim, Charles; Gold, Kathryn A.; Goldman, Jonathan W.; Grecula, John C.; Hann, Christine; Khalil, Maya; Lee, Robert; Malhotra, Jyoti; Merritt, Robert E.; Mohindra, Nisha; Molina, Julian R.; Moran, Cesar; Mulvey, Claire; Osmundson, Evan C.; Patel, Shiven; Patil, Tejas; Pokharel, Saraswati; Puri, Sonam; Qin, Angel; Sands, Jacob; Shields, Misty; Tailor, Tina D.; Waqar, Saiama N.; Cassara, Carly J.; Ramakrishnan, Swathi
Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer

立体定向体部放射治疗在Ⅰ期非小细胞肺癌中的应用趋势

CHEST
IF8.6
2025-11-120
PRE
Sara Sakowitz; Haley I. Tupper; Lawrence N. Benjamin; Scott Oh; Tao He; Reza Ronaghi; Colleen L. Channick; Brian J. Rosenberg; Ramin Salehi-rad; Malcolm I. Smith; Joanne M. Bando; Timothy J. Young; Igor Barjaktarvic; Maria A. Velez Velez; Arjan Gower; Amy L. Cummings; Jonathan Goldman; Aaron E. Lisberg; Edward B. Garon; Jane Yanagawa
Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report

奥希替尼联合萨沃利替尼治疗在一线奥希替尼治疗后具有MET改变的EGFR突变晚期NSCLC患者：临床结局、安全性和生物标志物分析：简要报告

Journal of Thoracic Oncology
IF20.8
2025-10-210
PRE
Xiuning Le; Christina Baik; Byoung Chul Cho; Jonathan W. Riess; Zofia Piotrowska; Adrianus Johannes de Langen; Sarah B. Goldberg; Jonathan W. Goldman; Noemi Reguart; Yoshimasa Shiraishi; Helen Ambrose; Paula G. Fraenkel; Brayan Merchan Ruiz; Paul E. Smith; Kwan Ho Tang; Helena A. Yu
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

poziotinib 用于 EGFR 外显子 20 插入型 NSCLC：ZENITH II 期试验的临床疗效及 EGFR 外显子 20 插入位点对敏感性的差异化影响

Nature Communications
IF15.7
2025-09-240
OAAI
Xiuning Le; Jacqulyne P. Robichaux; Monique Nilsson; R. S. K. Vijayan; Ashwin Ravichandran; Jia Wu; Yasir Y. Elamin; Lingzhi Hong; Jun Pei; Jun He; Sonia Patel; Hibiki Udagawa; Sriramvignesh Mani; Chang Woon Jang; Jeffrey M. Clarke; Nishan Tchekmedyian; Jonathan W. Goldman; Mark Socinski; Gajanan Bhat; Sharon Leu; Veronica Bunn; Zhenqiang Su; Sylvie Vincent; John W. Lawson; Jason B. Cross; John V. Heymach
Durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: outcomes in age, sex, and platinum subgroups from the phase 3 CASPIAN study

度伐利尤单抗联合铂类-依托泊苷治疗广泛期小细胞肺癌：CASPIAN III期研究中不同年龄、性别和铂类亚组的结果

Clinical Lung Cancer
IF3.3
2025-08-050
OAAI
Niels Reinmuth; Jonathan W. Goldman; Yuanbin Chen; Katsuyuki Hotta; Dmytro Trukhin; Galina Statsenko; Maximilian Hochmair; Mustafa Özgüroğlu; Jun Ho Ji; Marina Chiara Garassino; Artem Poltoratskiy; Francesco Verderame; Libor Havel; Igor Bondarenko; György Losonczy; Nikolay Conev; Shannon Kummer; Helen Mann; Priti Chugh; Tapashi Dalvi; Luis Paz-Ares
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC—A Brief Report

更新了来自II期PHAROS研究的encorafenib联合binimetinib在BRAF V600E突变型转移性NSCLC患者中的疗效和安全性——简报

Journal of Thoracic Oncology
IF20.8
2025-06-040
OAAI
Gregory J. Riely; Myung-Ju Ahn; Jeffrey M. Clarke; Ibiayi Dagogo-Jack; Raymond Esper; Enriqueta Felip; Francesco Gelsomino; Jonathan W. Goldman; Maen Hussein; Melissa Johnson; Kristen A. Marrone; Daniel Morgensztern; Ernest Nadal; Marcelo V. Negrao; Michael Offin; Mariano Provencio; Suresh S. Ramalingam; Logan Roof; Rachel E. Sanborn; Egbert F. Smit; Anne Tsao; Tiziana Usari; Ann Alcasid; Keith Wilner; Svitlana Tonkovyd; Xiaosong Zhang; Bruce E. Johnson
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study

Amivantamab在晚期NSCLC和MET外显子14跳跃突变参与者中的应用: CHRYSALIS研究的最终结果

Journal of Thoracic Oncology
IF20.8
2025-05-160
PREAI
Matthew G. Krebs; Byoung Chul Cho; Sandrine Hiret; Ji-Youn Han; Ki Hyeong Lee; Casilda Llácer Pérez; Filippo De Braud; Eric B. Haura; Rachel E. Sanborn; James Chih-Hsin Yang; Catherine A. Shu; Koichi Goto; Makoto Nishio; Jun Zhao; Zhijie Wang; Pascale Tomasini; Enriqueta Felip; Jonathan W. Goldman; Sai-Hong Ignatius Ou; Michael Boyer; Grace Gao; Siyang Qu; Joshua C. Curtin; Xuesong Lyu; Robert W. Schnepp; Priya Kim; Meena Thayu; Roland E. Knoblauch; Patricia Lorenzini; Mahadi Baig; Alexander I. Spira; Natasha B. Leighl
Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib

telisotuzumab vedotin联合奥希替尼治疗c-met蛋白过度表达、EGFR突变的局部晚期/转移性非小细胞肺癌 (NSCLC) 患者的Ib期研究结果

ANNALS OF ONCOLOGY
IF65.4
2025-01-012
PRE
Horinouchi, H.; Cho, B. C.; Camidge, D. R.; Goto, K.; Tomasini, P.; Li, Y.; Vasilopoulos, A.; Brunsdon, P.; Hoffman, D.; Shi, W.; Bolotin, E.; Blot, V.; Goldman, J.
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

CTLA4阻断消除KEAP1/STK11-related对PD-(L)1抑制剂的抗性

Nature
IF48.5
2024-10-090
OAAI
Ferdinandos Skoulidis; Haniel A. Araujo; Minh Truong Do; Yu Qian; Xin Sun; Ana Galan-Cobo; John T. Le; Meagan Montesion; Rachael Palmer; Nadine Jahchan; Joseph M. Juan; Chengyin Min; Yi Yu; Xuewen Pan; Kathryn C. Arbour; Natalie Vokes; Stephanie T. Schmidt; David Molkentine; Dwight H. Owen; Regan Memmott; Pradnya D. Patil; Melina E. Marmarelis; Mark M. Awad; Joseph C. Murray; Jessica A. Hellyer; Justin F. Gainor; Anastasios Dimou; Christine M. Bestvina; Catherine A. Shu; Jonathan W. Riess; Collin M. Blakely; Chad V. Pecot; Laura Mezquita; Fabrizio Tabbó; Matthias Scheffler; Subba Digumarthy; Meghan J. Mooradian; Adrian G. Sacher; Sally C. M. Lau; Andreas N. Saltos; Julia Rotow; Rocio Perez Johnson; Corinne Liu; Tyler Stewart; Sarah B. Goldberg; Jonathan Killam; Zenta Walther; Kurt Schalper; Kurtis D. Davies; Mark G. Woodcock; Valsamo Anagnostou; Kristen A. Marrone; Patrick M. Forde; Biagio Ricciuti; Deepti Venkatraman; Eliezer M. Van Allen; Amy L. Cummings; Jonathan W. Goldman; Hiram Shaish; Melanie Kier; Sharyn Katz; Charu Aggarwal; Ying Ni; Joseph T. Azok; Jeremy Segal; Lauren Ritterhouse; Joel W. Neal; Ludovic Lacroix; Yasir Y. Elamin; Marcelo V. Negrao; Xiuning Le; Vincent K. Lam; Whitney E. Lewis; Haley N. Kemp; Brett Carter; Jack A. Roth; Stephen Swisher; Richard Lee; Teng Zhou; Alissa Poteete; Yifan Kong; Tomohiro Takehara; Alvaro Guimaraes Paula; Edwin R. Parra Cuentas; Carmen Behrens; Ignacio I. Wistuba; Jianjun Zhang; George R. Blumenschein; Carl Gay; Lauren A. Byers; Don L. Gibbons; Anne Tsao; J. Jack Lee; Trever G. Bivona; D. Ross Camidge; Jhannelle E. Gray; Natasha B. Leighl; Benjamin Levy; Julie R. Brahmer; Marina C. Garassino; David R. Gandara; Edward B. Garon; Naiyer A. Rizvi; Giorgio Vittorio Scagliotti; Jürgen Wolf; David Planchard; Benjamin Besse; Roy S. Herbst; Heather A. Wakelee; Nathan A. Pennell; Alice T. Shaw; Pasi A. Jänne; David P. Carbone; Matthew D. Hellmann; Charles M. Rudin; Lee Albacker; Helen Mann; Zhou Zhu; Zhongwu Lai; Ross Stewart; Solange Peters; Melissa L. Johnson; Kwok K. Wong; Alan Huang; Monte M. Winslow; Michael J. Rosen; Ian P. Winters; Vassiliki A. Papadimitrakopoulou; Tina Cascone; Philip Jewsbury; John V. Heymach
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
MOLECULAR CANCER
IF33.9
2024-05-304
OAAI
Xie, Mingchao; Vuko, Miljenka; Rodriguez-Canales, Jaime; Zimmermann, Johannes; Schick, Markus; O'Brien, Cathy; Paz-Ares, Luis; Goldman, Jonathan W.; Garassino, Marina Chiara; Gay, Carl M.; Heymach, John V.; Jiang, Haiyi; Barrett, J. Carl; Stewart, Ross A.; Lai, Zhongwu; Byers, Lauren A.; Rudin, Charles M.; Shrestha, Yashaswi
Phase I trial of intratumoral administration of autologous CCL21 gene-modified dendritic cells in combination with pembrolizumab for advanced NSCLC: Feasibility of repeated IT injections
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Liu, Bin; Lisberg, Aaron; Salehi-Rad, Ramin; Oh, Michael; Lee, Jay M.; Tran, Linh M.; Krysan, Kostyantyn; Lim, Raymond J.; Dumitras, Camelia; Jing, Zhe; Abtin, Fereidoun; Suh, Robert D.; Genshaft, Scott J.; Oh, Scott S.; Fishbein, Gregory A.; Kaul, Anita; Kahlon, Kanwarpal S.; Ashouri, Shahryar A.; Goldman, Jonathan W.; Elashoff, David A.; Garon, Edward; Dubinett, Steven M.
Amivantamab in wild-type advanced non-small cell lung cancer after disease progression on checkpoint inhibition and chemotherapy: Results from the phase 1b CHRYSALIS study
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Cho, Byoung Chul; Goldman, Jonathan; Leighl, Natasha; De Braud, Filippo; Lee, Ki Hyeong; Ghiringhelli, Francois; Garrido, Pilar; Peguero, Julio; Besse, Benjamin; Cassier, Philippe; Girard, Nicolas; de Miguel, Maria; Alvarez, Rosa; Greystroke, Alastair; Ohe, Yuichiro; Hsia, Te-Chun; Curtin, Joshua C.; Chowdhury, Sanjib; Lyu, Xuesong; Gao, Grace; Qu, Siyang; Lorenzini, Patricia; Kapoor, Aastha; Kim, Priya; Baig, Mahadi; Thayu, Meena; Knoblauch, Roland E.; Hiret, Sandrine; Tomasini, Pascale
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results

共享新抗原疫苗联合免疫检查点阻断治疗晚期转移性实体瘤: 1期临床试验中期结果

NATURE MEDICINE
IF50
2024-03-2716
PRE
Rappaport, Amy R.; Kyi, Chrisann; Lane, Monica; Hart, Meghan G.; Johnson, Melissa L.; Henick, Brian S.; Liao, Chih-Yi; Mahipal, Amit; Shergill, Ardaman; Spira, Alexander I.; Goldman, Jonathan W.; Scallan, Ciaran D.; Schenk, Desiree; Palmer, Christine D.; Davis, Matthew J.; Kounlavouth, Sonia; Kemp, Lindsey; Yang, Aaron; Li, Yaojun John; Likes, Molly; Shen, Annie; Boucher, Gregory R.; Egorova, Milana; Veres, Robert L.; Espinosa, J. Aaron; Jaroslavsky, Jason R.; Tardif, Lauren D. Kraemer; Acrebuche, Lindsey; Puccia, Christopher; Sousa, Leiliane; Zhou, Rita; Bae, Kyounghwa; Hecht, J. Randolph; Carbone, David P.; Johnson, Benny; Allen, Andrew; Ferguson, Andrew R.; Jooss, Karin
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

研究总结: 奥希替尼治疗EGFR突变非小细胞肺癌的总生存期

TARGETED ONCOLOGY
IF4
2024-03-110
OAAI
Tsuboi, Masahiro; Herbst, Roy S.; John, Thomas; Kato, Terufumi; Majem, Margarita; Grohe, Christian; Wang, Jie; Goldman, Jonathan W.; Lu, Shun; de Marinis, Filippo; Shepherd, Frances A.; Lee, Ki Hyeong; Le, Nhieu Thi; Dechaphunkul, Arunee; Kowalski, Dariusz; Bonanno, Laura; Domine, Manuel; Poole, Lynne; Bolanos, Ana; Rukazenkov, Yuri; Wu, Yi-Long
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer
FUTURE ONCOLOGY
IF2.6
2024-02-150
OAAI
Riely, Gregory J.; Smit, Egbert F.; Ahn, Myung-Ju; Felip, Enriqueta; Ramalingam, Suresh S.; Tsao, Anne; Johnson, Melissa; Gelsomino, Francesco; Esper, Raymond; Nadal, Ernest; Offin, Michael; Provencio, Mariano; Clarke, Jeffrey; Hussein, Maen; Otterson, Gregory A.; Dagogo-Jack, Ibiayi; Goldman, Jonathan W.; Morgensztern, Daniel; Alcasid, Ann; Usari, Tiziana; Wissel, Paul; Wilner, Keith; Pathan, Nuzhat; Tonkovyd, Svitlana; Johnson, Bruce E.
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-11-3091
PRE
Zhou, Caicun; Tang, Ke-Jing; Cho, Byoung Chul; Liu, Baogang; Paz-Ares, Luis; Cheng, Susanna; Kitazono, Satoru; Thiagarajan, Muthukkumaran; Goldman, Jonathan W.; Sabari, Joshua K.; Sanborn, Rachel E.; Mansfield, Aaron S.; Hung, Jen-Yu; Boyer, Michael; Popat, Sanjay; Mourao Dias, Josiane; Felip, Enriqueta; Majem, Margarita; Gumus, Mahmut; Kim, Sang-we; Ono, Akira; Xie, John; Bhattacharya, Archan; Agrawal, Trishala; Shreeve, S. Martin; Knoblauch, Roland E.; Park, Keunchil; Girard, Nicolas; PAPILLON Investigators

研究方向

暂未获取到该数据
E
Edward B. Garon
H 指数:76论文数:736被引数:5.5万
L
Luis Paz‐Ares
H 指数:116论文数:1,393被引数:9.4万
D
D. Ross Camidge
H 指数:110论文数:999被引数:6.3万
L
Lee S. Rosen
H 指数:0论文数:1被引数:14
M
Mustafa Özgüroğlu
H 指数:61论文数:549被引数:4.2万
A
Aaron Lisberg
H 指数:27论文数:197被引数:9,774
T
Thomas John
H 指数:66论文数:530被引数:2.9万
M
Margarita Majem
H 指数:55论文数:536被引数:2.4万
Z
Zofia Piotrowska
H 指数:42论文数:347被引数:1.0万
F
Frances A. Shepherd
H 指数:127论文数:1,119被引数:8.1万